Search for: "PFIZER" Results 181 - 200 of 4,638
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Jan 2023, 8:14 am by alath
Pfizer/BioNTech’s response: Pfizer and BioNTech claim that Moderna is misappropriating the hard work and independent research performed by an entire field of research in the years before COVID-19 emerged. [read post]
14 Jun 2010, 3:58 am by Bob Kraft
 Pfizer denies the allegations, but settled a similar case with the federal government and more than 40 states last year. [read post]
2 Mar 2009, 7:51 pm
An October 2008 photograph of a Pfizer sales representative taking a picture of students on the Harvard Medical School campus demonstrating against pharmaceutical company influence.Story in New York Times today.Additional web pages: InSync Communication, Drug Expert Witness. [read post]
12 Feb 2021, 4:15 am by La'Cee Conley
Pfizer and BioNTech have hit back at Allele Biotechnology and Pharmaceuticals, Inc. [read post]
23 Feb 2019, 7:15 am by IPWatchdog
A pharmaceutical analyst for UBS downgraded Pfizer from buy to neutral, citing the loss of patent protection in the 2025 to 2029 timeframe for several drugs which contributed 30 percent of Pfizer’s total revenue in 2015. [read post]
8 Dec 2020, 5:18 pm by Sabrina I. Pacifici
Vaccines and Related Biological Products Advisory Committee Meeting – December 10, 2020 – FDA Briefing Document Pfizer-BioNTech COVID-19 Vaccine: “On November 20, 2020, Pfizer and BioNTech (the Sponsor) submitted an Emergency Use Authorization (EUA) request to FDA for an investigational COVID-19 vaccine (BNT162b2) intended to prevent COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). [read post]
31 Jan 2024, 1:15 pm by Eileen McDermott
In a recent brief to the Patent Trial and Appeal Board (PTAB), Pfizer and BioNTech (Pfizer) told PTAB judges that Moderna’s dismissal of prior art listed in Pfizer’s August 2023 petition for inter partes review (IPR) of Moderna’s patent on mRNA vaccine technology is inconsistent with its declarations to the Food and Drug Administration (FDA) during the drug approval process. [read post]
31 Jan 2024, 1:15 pm by Eileen McDermott
In a recent brief to the Patent Trial and Appeal Board (PTAB), Pfizer and BioNTech (Pfizer) told PTAB judges that Moderna’s dismissal of prior art listed in Pfizer’s August 2023 petition for inter partes review (IPR) of Moderna’s patent on mRNA vaccine technology is inconsistent with its declarations to the Food and Drug Administration (FDA) during the drug approval process. [read post]
28 Jan 2022, 5:58 am by Allan Blutstein
Pfizer in Texas showdown: Court hearing this week will decide if it can assist FDA in providing COVID documentsBy Kevin Dunleavy, Fierce Pharma, Jan. 27, 2022Texas federal judge Mark Pittman will conduct a hearing on Friday to consider whether to allow Pfizer to participate in the redaction and release of information about the development of its COVID-19 vaccine, Comirnaty.Earlier this month, Pittman ruled that the FDA would have to turn over 55,000 pages of… [read post]
[Pfizer’s attempt to help patients cover co-pays] is specifically designed to induce Medicare beneficiaries to purchase Pfizer’s tafamidis, a federally reimbursable drug. [read post]
15 Dec 2020, 7:12 pm by Staff
FDA granted an Emergency Use Authorization to a COVID-19 vaccine developed by Pfizer, Inc. [read post]
20 May 2016, 6:36 am by Shriram T. Eachambadi
Pfizer announced its decision to restrict the sale of seven products that have been part of lethal injection protocols in some states. [read post]
18 Nov 2020, 5:35 am by Associated Press
The announcement, just a week after Pfizer first revealed promising preliminary results, comes as the company is preparing within days to formally ask U.S. ... [read post]
29 Aug 2023, 4:15 am by Eileen McDermott
Pfizer/ BioNTech told the PTAB that Moderna’s patents include “unimaginably broad claims directed to a basic idea” and asked the Board to cancel all of the challenged claims of both patents. [read post]
26 Jun 2007, 1:05 pm
Pfizer lawyers argued that the case had been improperly filed by government prosecutors. [read post]